-
公开(公告)号:US20050038086A1
公开(公告)日:2005-02-17
申请号:US10845467
申请日:2004-05-12
申请人: Gary Ashley , Robert Arslanian , John Carney , Brian Metcalf , Li Tang
发明人: Gary Ashley , Robert Arslanian , John Carney , Brian Metcalf , Li Tang
IPC分类号: C07D313/00 , C07D405/06 , C07D413/06 , C07D417/06 , C07D491/04 , C12N1/20 , C12N9/00 , C12N15/52 , C12N15/74 , C12P17/16 , C12P17/18 , C07D417/02 , A61K31/427
CPC分类号: C07D405/06 , C07D313/00 , C07D413/06 , C07D417/06 , C07D491/04 , C12N1/20 , C12N9/00 , C12N15/52 , C12N15/74 , C12P17/16 , C12P17/181 , C12R1/01
摘要: This invention relates to compounds of formula (I) and to pharmaceutically acceptable salts and solvates thereof, wherein R1, R2, R3, R4, R5, W, X, Y, and Ar are as defined herein. Compounds of formula (I) are useful in the treatment of diseases or conditions characterized by cellular hyperproliferation. This invention also relates to means for the preparation of compounds of formula (I); formulations containing compounds of formula (I); and methods for the use of said compounds and formulations in the treatment of a disease or condition characterized by cellular hyperproliferation, including cancer.
摘要翻译: 本发明涉及式(I)化合物及其药学上可接受的盐和溶剂化物,其中R 1,R 2,R 3,R 4,R 5,W,X,Y ,Ar如本文所定义。 式(I)化合物可用于治疗以细胞过度增殖为特征的疾病或病症。 本发明还涉及制备式(I)化合物的方法; 含有式(I)化合物的制剂; 以及在治疗以细胞过度增殖为特征的疾病或病症(包括癌症)中使用所述化合物和制剂的方法。
-
公开(公告)号:US07070964B2
公开(公告)日:2006-07-04
申请号:US10295342
申请日:2002-11-14
申请人: Li Tang , Brian Metcalf , Leonard Katz , Gary Ashley
发明人: Li Tang , Brian Metcalf , Leonard Katz , Gary Ashley
IPC分类号: C12P17/00
CPC分类号: C07D417/06 , C07D493/04 , C07D493/08 , C12P17/167 , C12P17/181
摘要: The present invention provides bioconversion methods for making epothilone analogs. These analogs differ from the starting material by the addition of one or more hydroxyl groups or by the addition of an epoxide. These compounds, in turn, can be further modified by chemical synthesis.
摘要翻译: 本发明提供用于制备埃坡霉素类似物的生物转化方法。 这些类似物通过加入一个或多个羟基或通过加入环氧化物与原料不同。 这些化合物又可以通过化学合成进一步改性。
-
公开(公告)号:US07176235B2
公开(公告)日:2007-02-13
申请号:US10845467
申请日:2004-05-12
申请人: Gary Ashley , John R. Carney , Brian Metcalf
发明人: Gary Ashley , John R. Carney , Brian Metcalf
IPC分类号: A61K31/335 , C07D225/04 , C07D491/00 , C07D225/02
CPC分类号: C07D405/06 , C07D313/00 , C07D413/06 , C07D417/06 , C07D491/04 , C12N1/20 , C12N9/00 , C12N15/52 , C12N15/74 , C12P17/16 , C12P17/181 , C12R1/01
摘要: This invention relates to compounds of formula (I) and to pharmaceutically acceptable salts and solvates thereof, wherein R1, R2, R3, R4, R5, W, X, Y, and Ar are as defined herein. Compounds of formula (I) are useful in the treatment of diseases or conditions characterized by cellular hyperproliferation. This invention also relates to means for the preparation of compounds of formula (I); formulations containing compounds of formula (I); and methods for the use of said compounds and formulations in the treatment of a disease or condition characterized by cellular hyperproliferation, including cancer.
摘要翻译: 本发明涉及式(I)化合物及其药用盐和溶剂合物,其中R 1,R 2,R 3, R 4,R 5,W,X,Y和Ar如本文所定义。 式(I)化合物可用于治疗以细胞过度增殖为特征的疾病或病症。 本发明还涉及制备式(I)化合物的方法; 含有式(I)化合物的制剂; 以及在治疗以细胞过度增殖为特征的疾病或病症(包括癌症)中使用所述化合物和制剂的方法。
-
公开(公告)号:US06893859B2
公开(公告)日:2005-05-17
申请号:US10115198
申请日:2002-04-02
申请人: Gary Ashley , Robert L. Arslanian , John Carney , Brian Metcalf , Li Tang
发明人: Gary Ashley , Robert L. Arslanian , John Carney , Brian Metcalf , Li Tang
IPC分类号: C07D313/00 , C07D405/06 , C07D413/06 , C07D417/06 , C07D491/04 , C12N1/20 , C12N9/00 , C12N15/52 , C12N15/74 , C12P17/16 , C12P17/18 , C12N1/21
CPC分类号: C07D405/06 , C07D313/00 , C07D413/06 , C07D417/06 , C07D491/04 , C12N1/20 , C12N9/00 , C12N15/52 , C12N15/74 , C12P17/16 , C12P17/181 , C12R1/01
摘要: This invention relates to compounds of formula (I) and to pharmaceutically acceptable salts and solvates thereof, wherein R1, R2, R3, R4, R5, W, X, Y, and Ar are as defined herein. Compounds of formula (I) are useful in the treatment of diseases or conditions characterized by cellular hyperproliferation. This invention also relates to means for the preparation of compounds of formula (I); formulations containing compounds of formula (I); and methods for the use of said compounds and formulations in the treatment of a disease or condition characterized by cellular hyperproliferation, including cancer.
摘要翻译: 本发明涉及式(I)化合物及其药用盐和溶剂合物,其中R 1,R 2,R 3, R 4,R 5,W,X,Y和Ar如本文所定义。 式(I)化合物可用于治疗以细胞过度增殖为特征的疾病或病症。 本发明还涉及制备式(I)化合物的方法; 含有式(I)化合物的制剂; 以及在治疗以细胞过度增殖为特征的疾病或病症(包括癌症)中使用所述化合物和制剂的方法。
-
公开(公告)号:US06815463B2
公开(公告)日:2004-11-09
申请号:US10364111
申请日:2003-02-10
申请人: Gary Ashley , Brian Metcalf
发明人: Gary Ashley , Brian Metcalf
IPC分类号: C07D41706
CPC分类号: C07D493/08
摘要: Laulimalide compounds, intermediates thereto and methods for their preparation, and methods for their use in the treatment of diseases characterized by cellular hyperproliferation.
-
公开(公告)号:US06670389B2
公开(公告)日:2003-12-30
申请号:US10071839
申请日:2002-02-08
申请人: Gary Ashley , Brian Metcalf
发明人: Gary Ashley , Brian Metcalf
IPC分类号: C07D41706
CPC分类号: C07D493/08
摘要: Laulimalide compounds, intermediates thereto and methods for their preparation, and methods for their use in the treatment of diseases characterized by cellular hyperproliferation.
-
公开(公告)号:US06489314B1
公开(公告)日:2002-12-03
申请号:US09825856
申请日:2001-04-03
申请人: Gary Ashley , Brian Metcalf
发明人: Gary Ashley , Brian Metcalf
IPC分类号: A61K3133
CPC分类号: C07D405/06 , C07D313/00 , C07D413/06 , C07D417/06 , C07D491/04 , C12N1/20 , C12N9/00 , C12N15/52 , C12N15/74 , C12P17/16 , C12P17/181 , C12R1/01
摘要: The present invention relates to 16-membered macrocyclic compounds. In one aspect of the present invention, compounds of the formula are provided wherein: R1, R2, R3, and R5 are each independently hydrogen, C1-C10 alkyl, C2-C10 alkenyl, C2-C10 alkynyl, aryl or alkylaryl; R4 is hydrogen, halogen, C1-C10 alkyl, C1-C10 hydroxyalkyl, C1-C10 haloalkyl, aryl, —C(═O)R6, —C(═O)OR6, —NR6R7 where R6 and R7 are each independently hydrogen, C1-C10 aliphatic, aryl or alkylaryl; W is O, NR8 where R8 is hydrogen, C1-C10 alkyl, C2-C10 alkenyl, C2-C10 alkynyl, aryl or alkylaryl; X is O, CH2 or a carbon-carbon double bond; Y is absent or a C1-C10 alkyl, C2-C10 alkenyl, or C2-C10 alkynyl; and Ar is aryl; provided that 10,11-dehydroepothilone C is excluded.
摘要翻译: 本发明涉及16元大环化合物。 在本发明的一个方面,提供下列化合物,其中:R1,R2,R3和R5各自独立地为氢,C1-C10烷基,C2-C10烯基,C2-C10炔基,芳基或烷基芳基; R4为氢 卤素,C 1 -C 10烷基,C 1 -C 10羟基烷基,C 1 -C 10卤代烷基,芳基,-C(= O)R 6,-C(= O)OR 6,-NR 6 R 7,其中R 6和R 7各自独立地为氢, 脂族,芳基或烷基芳基; W是O,NR8,其中R8是氢,C1-C10烷基,C2-C10烯基,C2-C10炔基,芳基或烷基芳基; X是O,CH2或碳 - 碳双键; Y是 不存在或C 1 -C 10烷基,C 2 -C 10烯基或C 2 -C 10炔基; 且Ar为芳基; 条件是排除了10,11-脱氢抗坏血酸酮C.
-
公开(公告)号:US08754190B2
公开(公告)日:2014-06-17
申请号:US13696299
申请日:2011-05-05
申请人: Gary Ashley , Daniel V. Santi
发明人: Gary Ashley , Daniel V. Santi
IPC分类号: A61K38/06 , C07K5/00 , C07K7/00 , C07K16/00 , C07K17/00 , C07D487/00 , C07D491/00 , C07D513/00 , C07D239/02 , C07C247/00 , C07J41/00
CPC分类号: A61K47/48215 , A61K9/0019 , A61K9/08 , A61K47/54 , A61K47/60 , C07D487/04 , C07D491/22
摘要: The invention relates to conjugates of macromolecular carriers and drugs comprising linkers that release the drug or a prodrug through rate-controlled beta-elimination, and methods of making and using the conjugates.
摘要翻译: 本发明涉及大分子载体的缀合物和包含通过速率控制的β-消除释放药物或前药的接头的药物,以及制备和使用缀合物的方法。
-
公开(公告)号:US20130123487A1
公开(公告)日:2013-05-16
申请号:US13696300
申请日:2011-05-05
申请人: Gary Ashley , Daniel V. Santi
发明人: Gary Ashley , Daniel V. Santi
IPC分类号: A61K47/48
CPC分类号: A61K47/48215 , A61K47/58 , A61K47/60 , A61K47/6435 , A61K47/6903 , A61K47/6953 , A61K47/6957 , A61K49/0043 , A61K49/0054 , A61L15/44 , A61L27/54 , A61L29/16 , A61L31/16 , A61L2300/252 , A61L2300/258
摘要: The invention relates to solid supports useful in medical applications that provide controlled release of drugs, such as peptides, nucleic acids and small molecules. The drugs are covalently coupled to the solid support through a linkage that releases the drug or a prodrug through controlled beta elimination.
摘要翻译: 本发明涉及用于医疗应用中的固体支持物,其提供药物如肽,核酸和小分子的受控释放。 这些药物通过通过控制β消除释放药物或前药的连接共价偶联到固体支持物上。
-
10.
公开(公告)号:US07049100B2
公开(公告)日:2006-05-23
申请号:US10104417
申请日:2002-03-22
申请人: Daniel V. Santi , Qun Xue , Gary Ashley
发明人: Daniel V. Santi , Qun Xue , Gary Ashley
CPC分类号: C07H17/08 , A01K2217/05 , C07K2319/00 , C12N9/00 , C12N9/1025 , C12N9/1288 , C12N15/52 , C12N15/70 , C12N15/76 , C12N15/81 , C12P7/26 , C12P7/42 , C12P17/08 , C12P19/62 , C40B40/00
摘要: A multiple-plasmid system for heterologous expression of polyketides facilitates combinatorial biosynthesis. The method can be extended to any modular polyketide synthase (PKS) or non-ribosomal peptide synthase (NRPS) and has the potential to produce thousands of novel natural products, including ones derived from further modification of the PKS or NRPS products by tailoring enzymes.
-
-
-
-
-
-
-
-
-